Ferrous iron-dependent delivery of therapeutic agents to the malaria parasite

Sumit S Mahajan1, Jiri Gut, Philip J Rosenthal

  • 1Small Molecule Discovery Center, Department of Pharmaceutical Chemistry, University of California, San Francisco, Byers Hall 503D, 1700 4th Street, San Francisco, CA 94158, USA.

Future Medicinal Chemistry
|December 14, 2012
PubMed
Abstract

Insights

Researchers developed novel 'fragmenting hybrids' for targeted malaria drug delivery. These compounds release drugs selectively inside Plasmodium parasites, triggered by iron, enhancing treatment efficacy.

Area of Science:

  • Medicinal Chemistry
  • Parasitology
  • Drug Delivery Systems

Background:

  • Malaria parasites (Plasmodium falciparum, Plasmodium vivax) produce toxic free iron heme during hemoglobin digestion.
  • This parasite-specific iron accumulation presents a unique target for selective drug delivery.
  • Current drug development focuses on intra-erythrocytic parasite targeting.

Purpose of the Study:

  • To develop and validate a novel drug delivery system for malaria parasites.
  • To demonstrate parasite-selective drug release triggered by ferrous iron.
  • To create 'fragmenting hybrids' for targeted therapeutic delivery.

Main Methods:

  • Development of 'fragmenting hybrids' incorporating a 1,2,4-trioxolane iron(II)-sensing trigger.
  • Utilizing a 'traceless' retro-Michael linker for drug attachment.
  • Employing three orthogonal experimental approaches for in vitro proof-of-concept validation.

Main Results:

  • Successful in vitro proof-of-concept for ferrous iron-dependent drug delivery was achieved.
  • Two fragmenting hybrids demonstrated effective partner drug delivery to live P. falciparum parasites.
  • The system successfully masked partner drug bioactivity until release within the parasite.

Conclusions:

  • Fragmenting hybrids enable targeted drug delivery to intra-erythrocytic malaria parasites.
  • Ferrous iron-triggered release mechanism proves effective for parasite-selective therapy.
  • This approach offers a strategy to mask drug activity, improving therapeutic index.

Related Concept Videos

The Early Endosome: Endocytosis of Transferrin01:28

The Early Endosome: Endocytosis of Transferrin

Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Microbes and Other Elemental Cycles01:24

Microbes and Other Elemental Cycles

Microbial activity plays a pivotal role in the biogeochemical cycling of iron and manganese, especially at the redox gradients characteristic of stratified aquatic environments. These cycles are driven by microbial transformations between oxidized and reduced forms of the metals, allowing organisms to exploit them for metabolic energy and structural purposes.Iron Cycling Across Redox GradientsIn neutral, oxygen-rich surface waters, iron is predominantly found in its oxidized, insoluble ferric...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Symbiosis00:58

Symbiosis

Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...